75 related articles for article (PubMed ID: 10633477)
1. CSF SNAP-25 in schizophrenia and bipolar illness. A pilot study.
Thompson PM; Rosenberger C; Qualls C
Neuropsychopharmacology; 1999 Dec; 21(6):717-22. PubMed ID: 10633477
[TBL] [Abstract][Full Text] [Related]
2. Elevated cerebrospinal fluid SNAP-25 in schizophrenia.
Thompson PM; Kelley M; Yao J; Tsai G; van Kammen DP
Biol Psychiatry; 2003 Jun; 53(12):1132-7. PubMed ID: 12814864
[TBL] [Abstract][Full Text] [Related]
3. SNAP-25 reduction in the hippocampus of patients with schizophrenia.
Thompson PM; Egbufoama S; Vawter MP
Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):411-7. PubMed ID: 12691775
[TBL] [Abstract][Full Text] [Related]
4. Measuring synaptosomal associated protein-25 kDa in human cerebral spinal fluid.
Thompson PM; Rosenberger C; Holt S; Perrone-Bizzozero NI
J Psychiatr Res; 1998; 32(5):297-300. PubMed ID: 9789208
[TBL] [Abstract][Full Text] [Related]
5. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.
Müller DJ; Klempan TA; De Luca V; Sicard T; Volavka J; Czobor P; Sheitman BB; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA; Honer WG; Kennedy JL
Neurosci Lett; 2005 May; 379(2):81-9. PubMed ID: 15823421
[TBL] [Abstract][Full Text] [Related]
6. Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder.
Gray LJ; Dean B; Kronsbein HC; Robinson PJ; Scarr E
Psychiatry Res; 2010 Jul; 178(2):374-80. PubMed ID: 20488553
[TBL] [Abstract][Full Text] [Related]
7. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia.
Thompson PM; Sower AC; Perrone-Bizzozero NI
Biol Psychiatry; 1998 Feb; 43(4):239-43. PubMed ID: 9513732
[TBL] [Abstract][Full Text] [Related]
8. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia.
Fatemi SH; Earle JA; Stary JM; Lee S; Sedgewick J
Neuroreport; 2001 Oct; 12(15):3257-62. PubMed ID: 11711867
[TBL] [Abstract][Full Text] [Related]
9. Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis.
Regenold WT; Phatak P; Marano CM; Sassan A; Conley RR; Kling MA
Biol Psychiatry; 2009 Mar; 65(6):489-94. PubMed ID: 19103439
[TBL] [Abstract][Full Text] [Related]
10. CSF calcium: clinical correlates in affective illness and schizophrenia.
Jimerson DC; Post RM; Carman JS; van Kammen DP; Wood JH; Goodwin FK; Bunney WE
Biol Psychiatry; 1979 Feb; 14(1):37-51. PubMed ID: 420907
[TBL] [Abstract][Full Text] [Related]
11. Elevated cerebrospinal fluid protein in men with unipolar or bipolar depression.
Samuelson SD; Winokur G; Pitts AF
Biol Psychiatry; 1994 Apr; 35(8):539-44. PubMed ID: 8038297
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder.
Scarr E; Gray L; Keriakous D; Robinson PJ; Dean B
Bipolar Disord; 2006 Apr; 8(2):133-43. PubMed ID: 16542183
[TBL] [Abstract][Full Text] [Related]
13. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
[TBL] [Abstract][Full Text] [Related]
14. Identification of synaptic vesicle, pre- and postsynaptic proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing.
Davidsson P; Puchades M; Blennow K
Electrophoresis; 1999 Mar; 20(3):431-7. PubMed ID: 10217148
[TBL] [Abstract][Full Text] [Related]
15. SNAP-25 gene polymorphisms and weight gain in schizophrenic patients.
Musil R; Spellmann I; Riedel M; Dehning S; Douhet A; Maino K; Zill P; Müller N; Möller HJ; Bondy B
J Psychiatr Res; 2008 Oct; 42(12):963-70. PubMed ID: 18191416
[TBL] [Abstract][Full Text] [Related]
16. [Interaction between neuropeptides and monoamines--causing imbalance in physical diseases?].
Widerlöv E
Lakartidningen; 1984 Dec; 81(52):4943-6. PubMed ID: 6152004
[No Abstract] [Full Text] [Related]
17. Progressive brain changes in children and adolescents with first-episode psychosis.
Arango C; Rapado-Castro M; Reig S; Castro-Fornieles J; González-Pinto A; Otero S; Baeza I; Moreno C; Graell M; Janssen J; Parellada M; Moreno D; Bargalló N; Desco M
Arch Gen Psychiatry; 2012 Jan; 69(1):16-26. PubMed ID: 22213785
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
Behan AT; Byrne C; Dunn MJ; Cagney G; Cotter DR
Mol Psychiatry; 2009 Jun; 14(6):601-13. PubMed ID: 18268500
[TBL] [Abstract][Full Text] [Related]
19. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.
Beneyto M; Meador-Woodruff JH
Neuropsychopharmacology; 2008 Aug; 33(9):2175-86. PubMed ID: 18033238
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development.
Halim ND; Weickert CS; McClintock BW; Hyde TM; Weinberger DR; Kleinman JE; Lipska BK
Mol Psychiatry; 2003 Sep; 8(9):797-810. PubMed ID: 12931207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
